Ann Robinson, Director of Consumer Policy at uSwitch, says it's hard to know how much companies are paying for their energy which makes it difficult to work out if consumers are getting a fair deal.
More top news
Niraparib is a PARP inhibitor belonging to a new class of drugs that target cancers with defective DNA repair systems.
According to the EU, during the transition period the UK would have to comply with the bloc's trade policy.
Turning mild for the middle of the week.